Preclinical evaluation of <sup>213</sup>Bi-/<sup>225</sup>Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer
Sangeeta Ray(Johns Hopkins University), Martin G. Pomper(Southwestern Medical Center)
Cited by 39
Related Papers
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
|Biochemical and Biophysical Research Communications|2004|350
Future cancer research priorities in the USA: a Lancet Oncology Commission
|The Lancet Oncology|2017|209
Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients
|Tomography|2015|182